Profile data is unavailable for this security.
About the company
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral, coronary and structural heart. It manufactures vascular intervention medical devices, including drug-coated balloons, and radial access balloon catheters and guide sheaths. The IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
- Revenue in USD (TTM)138.20m
- Net income in USD5.52m
- Incorporated1979
- Employees376.00
- LocationSurmodics Inc9924 W 74th StEDEN PRAIRIE 55344United StatesUSA
- Phone+1 (952) 500-7000
- Fax+1 (952) 500-7001
- Websitehttps://www.surmodics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sight Sciences Inc | 81.06m | -55.55m | 254.70m | 214.00 | -- | 2.10 | -- | 3.14 | -1.14 | -1.14 | 1.67 | 2.45 | 0.4269 | 1.70 | 5.51 | 378,761.70 | -29.26 | -38.78 | -31.77 | -42.20 | 85.34 | 80.74 | -68.53 | -105.14 | 12.65 | -10.59 | 0.2201 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
| Edap Tms SA (ADR) | 64.83m | -22.72m | 275.39m | 307.00 | -- | 4.51 | -- | 4.25 | -0.6143 | -0.6143 | 1.75 | 1.65 | 0.6272 | 2.68 | 3.86 | 211,166.30 | -21.98 | -6.62 | -29.54 | -9.22 | 40.40 | 43.23 | -35.05 | -9.59 | 2.30 | -27.44 | 0.1045 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
| Pulmonx Corp | 68.68m | -60.84m | 283.33m | 279.00 | -- | 2.38 | -- | 4.13 | -1.60 | -1.60 | 1.81 | 3.07 | 0.3698 | 1.14 | 6.61 | 246,147.00 | -32.76 | -26.27 | -36.90 | -28.97 | 73.90 | 71.95 | -88.60 | -93.76 | 5.77 | -- | 0.2394 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
| AxoGen Inc | 159.01m | -21.72m | 284.95m | 426.00 | -- | 2.94 | -- | 1.79 | -0.5070 | -0.5070 | 3.71 | 2.22 | 0.8108 | 1.63 | 6.72 | 373,267.60 | -11.07 | -13.92 | -12.85 | -15.84 | 78.46 | 79.74 | -13.66 | -20.28 | 2.14 | -- | 0.3277 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| CVRx Inc | 39.30m | -41.20m | 310.76m | 200.00 | -- | 3.96 | -- | 7.91 | -1.99 | -1.99 | 1.89 | 3.64 | 0.3272 | 0.6974 | 6.02 | 196,475.00 | -34.31 | -- | -36.75 | -- | 84.08 | -- | -104.85 | -- | 12.86 | -23.96 | 0.2779 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
| Bioventus Inc | 502.76m | -122.57m | 322.20m | 970.00 | -- | 1.81 | -- | 0.6409 | -1.97 | -2.93 | 8.06 | 2.25 | 0.4552 | 2.14 | 4.10 | 448,889.30 | -14.34 | -- | -18.91 | -- | 62.87 | 70.26 | -31.51 | -9.18 | 0.9443 | 0.3731 | 0.6354 | -- | 18.85 | 11.89 | -919.12 | -- | -- | -- |
| Tactile Systems Technology Inc | 274.42m | 28.52m | 339.05m | 992.00 | 12.02 | 1.74 | 9.67 | 1.24 | 1.19 | 1.19 | 11.90 | 8.20 | 1.02 | 6.02 | 5.60 | 276,636.10 | 10.63 | 0.9015 | 13.23 | 1.09 | 49.95 | 49.10 | 10.39 | 0.8309 | 2.99 | -- | 0.1308 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
| Zynex Inc | 184.32m | 9.73m | 349.31m | 1.10k | 40.86 | 7.93 | 25.04 | 1.90 | 0.2677 | 0.2677 | 5.10 | 1.38 | 1.45 | 2.86 | 5.96 | 167,565.50 | 7.68 | 14.58 | 9.11 | 17.52 | 79.38 | 79.62 | 5.28 | 10.44 | 4.03 | 9.85 | 0.5581 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
| Pulse Biosciences Inc | 0.00 | -42.21m | 369.46m | 56.00 | -- | 8.32 | -- | -- | -0.8936 | -0.8936 | 0.00 | 0.8044 | 0.00 | -- | -- | 0.00 | -61.61 | -93.21 | -67.89 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
| Pacific Biosciences of California Inc | 200.52m | -306.74m | 369.77m | 796.00 | -- | 0.5269 | -- | 1.84 | -1.21 | -1.21 | 0.7907 | 2.62 | 0.1142 | 2.70 | 7.24 | 251,910.80 | -17.46 | -16.19 | -19.45 | -17.81 | 28.03 | 37.35 | -152.97 | -136.21 | 7.21 | -22.45 | 0.5601 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| Surmodics Inc | 138.20m | 5.52m | 372.56m | 376.00 | 66.92 | 3.05 | 26.14 | 2.70 | 0.3911 | 0.3911 | 9.82 | 8.58 | 0.7897 | 2.10 | 7.05 | 367,561.20 | 3.15 | -1.85 | 3.49 | -2.18 | 79.38 | 82.93 | 3.99 | -2.98 | 3.97 | 5.84 | 0.1942 | -- | 32.65 | 10.27 | 94.37 | -- | -27.02 | -- |
| Neuropace Inc | 65.42m | -32.96m | 373.07m | 171.00 | -- | 17.50 | -- | 5.70 | -1.28 | -1.28 | 2.53 | 0.7423 | 0.590 | 1.65 | 6.61 | 382,578.90 | -29.72 | -- | -33.88 | -- | 73.56 | -- | -50.38 | -- | 5.02 | -4.97 | 0.7339 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
| MaxCyte Inc | 41.29m | -37.92m | 385.22m | 143.00 | -- | 1.65 | -- | 9.33 | -0.3675 | -0.3675 | 0.3998 | 2.23 | 0.1488 | 0.4558 | 4.27 | 288,727.30 | -13.67 | -13.18 | -14.54 | -14.33 | 88.51 | 88.79 | -91.85 | -62.96 | 9.97 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
| ZimVie Inc | 457.43m | -56.05m | 421.38m | 2.60k | -- | 1.02 | -- | 0.9212 | -2.12 | -14.87 | 17.33 | 15.12 | 0.3213 | 1.07 | 3.91 | 175,935.80 | -3.94 | -- | -4.56 | -- | 63.48 | 65.51 | -12.25 | -8.73 | 2.32 | -0.5562 | 0.5541 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
| Nevro Corp | 425.17m | -92.21m | 426.24m | 1.22k | -- | 1.44 | -- | 1.00 | -2.57 | -2.57 | 11.82 | 8.06 | 0.6868 | 1.24 | 5.37 | 349,937.40 | -14.90 | -13.64 | -17.15 | -16.68 | 68.22 | 68.54 | -21.69 | -20.67 | 4.94 | -- | 0.4191 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
| Orthofix Medical Inc | 746.64m | -151.40m | 490.03m | 1.63k | -- | 0.8132 | -- | 0.6563 | -4.15 | -4.15 | 20.33 | 16.11 | 1.08 | 1.62 | 7.08 | 456,940.60 | -21.88 | -8.88 | -26.68 | -10.96 | 65.13 | 72.37 | -20.28 | -9.28 | 1.20 | -16.11 | 0.1595 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
Data as of Apr 25 2024. Currency figures normalised to Surmodics Inc's reporting currency: US Dollar USD
61.90%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Trigran Investments, Inc.as of 31 Dec 2023 | 2.36m | 16.57% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 1.15m | 8.10% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 1.00m | 7.04% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 831.48k | 5.84% |
| Soleus Capital Management LP (Investment Management)as of 31 Dec 2023 | 771.70k | 5.42% |
| Millennium Management LLCas of 31 Dec 2023 | 671.55k | 4.72% |
| Disciplined Growth Investors, Inc.as of 31 Dec 2023 | 614.89k | 4.32% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 584.14k | 4.10% |
| Royce & Associates LPas of 31 Dec 2023 | 420.41k | 2.95% |
| Segall Bryant & Hamill LLCas of 31 Dec 2023 | 404.17k | 2.84% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
